Development of symptomatic brain metastases after chemoradiotherapy for stage III non-small cell lung cancer: Does the type of chemotherapy regimen matter?-Reference-Cited by-同舟云学术

Development of symptomatic brain metastases after chemoradiotherapy for stage III non-small cell lung cancer: Does the type of chemotherapy regimen matter?

Published:2016-11 Issue: Volume:101 Page:68-75
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Hendriks Lizza E.L.,Brouns -->Anita J.W.M.,Amini Mohammad^ORCID,Uyterlinde Wilma,Wijsman Robin^ORCID,Bussink Jan,Biesma Bonne,Oei S. Bing,Stigt Jos -->A.,Bootsma Gerben P.,Belderbos José S.A.,De Ruysscher Dirk K.M.,Van den Heuvel Michel M.,Dingemans Anne-Marie C.

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference17 articles.

1. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer;Auperin;J. Clin. Oncol.,2010

2. NCCN Guidelines version 1.2015 Non-Small Cell Lung Cancer. 2014.

3. 2nd ESMO consensus conference in lung cancer: locally advanced stage III non-small-cell lung cancer;Eberhardt;Ann. Oncol.,2015

4. Time from treatment to subsequent diagnosis of brain metastases in stage III non-small-cell lung cancer: a retrospective review by the Southwest Oncology Group;Gaspar;J. Clin. Oncol.,2005

5. Screening for brain metastases in patients with stage III non-small cell lung cancer: is there additive value of magnetic resonance imaging above a contrast-enhanced computed tomography of the brain?;Hendriks;Lung Cancer,2013

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk factors for brain metastases in locally advanced non-small cell lung cancer patients treated with radical radiotherapy;Journal of Thoracic Disease;2024-01

2. Predictive value of baseline metabolic tumor burden on 18F-FDG PET/CT for brain metastases in patients with locally advanced non-small-cell lung cancer;Frontiers in Oncology;2022-10-26

3. Excessive esophageal toxicity in patients with locally advanced non-small cell lung cancer treated with concurrent hypofractionated chemoradiotherapy and 3-weekly platinum doublet chemotherapy;Clinical and Translational Radiation Oncology;2022-09

4. Investigation of the added value of CT-based radiomics in predicting the development of brain metastases in patients with radically treated stage III NSCLC;Therapeutic Advances in Medical Oncology;2022-01

5. Prophylactic Cranial Irradiation in Non-small Cell Lung Cancer;Medical Radiology;2022